Andrew J. Lickteig

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2009 · 342 citations · Full text

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · European Journal of Pharmacology · 2009 · 113 citations · Full text

Pathology, Fatty Liver Disease, Obesity +16

Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease

Andrew J. Lickteig, Craig D. Fisher, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2007 · 97 citations

Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice

Andrew J. Lickteig, Xingguo Cheng, Lisa M. Augustine et al. · Life Sciences · 2008 · 71 citations · Full text

Knockout Mouse, Transporters Multidrug, Developmental Biology +10

Intestine-Specific Deletion of SIRT1 in Mice Impairs DCoH2–HNF-1α–FXR Signaling and Alters Systemic Bile Acid Homeostasis

Nevzat Kazgan, Mallikarjuna R. Metukuri, Aparna Purushotham et al. · Gastroenterology · 2014 · 71 citations · Full text

Inflammation, Liver Physiology, Gastroenterology +9